Five-year follow-up results from the Phase 3 Study 309/KEYNOTE-775, presented at ESMO 2025, confirm that lenvatinib plus ...

A large AI-driven study of 3,476 cancer patients, presented at ESMO 2025, reveals that thymic health is strongly linked to ...

A new PNAS study unveils a hidden vulnerability of prostate cancer: the protein-disulfide isomerases , which stabilize (AR) ...

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

Researchers have developed self-assembling peptide nanotubes that deliver doxorubicin directly into the nucleus of ...

Researchers at the Institut Pasteur and Inserm have developed a novel triple-therapy that reprograms how B cell cancers ...

Researchers have developed a groundbreaking LED-based cancer therapy using tin oxide (SnOx) nanoflakes that selectively ...

AstraZeneca has reached a wide-ranging agreement with the Trump administration to cut prescription drug prices for American patients—offering up to 80% discounts via TrumpRx.gov—while investing $50 ...